

Diurnal Group
DNL:LNLondon Stock Exchange (AIM)
Overview
Company Profile
Diurnal Group plc is a European, UK-headquartered specialty pharmaceutical company dedicated to developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia, Adrenal Insufficiency, Hypogonadism and Hypothyroidism.
Classification
SectorHealthcare
ExchangeLondon Stock Exchange (AIM)
BoardAIM
